DR REDDYS LABORATORIES
Quarterly Results Analysis [Mar2024]
DR REDDYS LABORATORIES Quarterly Results
Consolidated | Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹7,114 Cr | ₹7,237 Cr | ₹6,903 Cr | ₹6,758 Cr | ₹6,315 Cr | ₹6,790 Cr | ₹6,332 Cr | ₹5,233 Cr |
Expenses | ₹5,283 Cr | ₹5,214 Cr | ₹4,894 Cr | ₹4,696 Cr | ₹4,781 Cr | ₹4,851 Cr | ₹4,433 Cr | ₹4,292 Cr |
Operating Income | ₹1,831 Cr | ₹2,023 Cr | ₹2,008 Cr | ₹2,062 Cr | ₹1,534 Cr | ₹1,939 Cr | ₹1,899 Cr | ₹941 Cr |
Other Income | ₹198 Cr | ₹216 Cr | ₹315 Cr | ₹174 Cr | ₹139 Cr | ₹59 Cr | ₹41 Cr | ₹854 Cr |
Interest | ₹59 Cr | ₹39 Cr | ₹35 Cr | ₹37 Cr | ₹35 Cr | ₹42 Cr | ₹31 Cr | ₹35 Cr |
Depreciation | ₹368 Cr | ₹374 Cr | ₹376 Cr | ₹353 Cr | ₹316 Cr | ₹324 Cr | ₹309 Cr | ₹302 Cr |
Profit Before Tax | ₹1,602 Cr | ₹1,826 Cr | ₹1,913 Cr | ₹1,846 Cr | ₹1,322 Cr | ₹1,632 Cr | ₹1,600 Cr | ₹1,459 Cr |
Profit After Tax | ₹1,306 Cr | ₹1,378 Cr | ₹1,478 Cr | ₹1,401 Cr | ₹953 Cr | ₹1,238 Cr | ₹1,100 Cr | ₹1,180 Cr |
EPS | ₹78.53 | ₹82.79 | ₹88.86 | ₹84.33 | ₹57.63 | ₹74.66 | ₹66.96 | ₹71.45 |
Industry Peers & Returns | 1W | 1M | 1Y |
DR REDDYS LABORATORIES | -3.7% | -1.4% | 26% |
SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -6.1% | 55.7% |
CIPLA | -2.5% | -5.1% | 48.6% |
ZYDUS LIFESCIENCES | 1.8% | 2.2% | 88.6% |
DIVIS LABORATORIES | -0.9% | 5% | 19.2% |
MANKIND PHARMA | -6.6% | -6.6% | NA |
TORRENT PHARMACEUTICALS | -3.2% | 1.8% | 57.6% |
LUPIN | -1.9% | 1.8% | 126.8% |
AUROBINDO PHARMA | -1.6% | 1.1% | 83.7% |
DR REDDYS LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.70 % |
Y-o-Y | 12.65 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹7,114 Cr | -1.70 | |
Dec2023 | ₹7,237 Cr | 4.84 | |
Sep2023 | ₹6,903 Cr | 2.14 | |
Jun2023 | ₹6,758 Cr | 7.01 | |
Mar2023 | ₹6,315 Cr | -6.99 | |
Dec2022 | ₹6,790 Cr | 7.23 | |
Sep2022 | ₹6,332 Cr | 21.00 | |
Jun2022 | ₹5,233 Cr | - |
DR REDDYS LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -9.49 % |
Y-o-Y | 19.38 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,831 Cr | -9.49 | |
Dec2023 | ₹2,023 Cr | 0.74 | |
Sep2023 | ₹2,008 Cr | -2.61 | |
Jun2023 | ₹2,062 Cr | 34.44 | |
Mar2023 | ₹1,534 Cr | -20.87 | |
Dec2022 | ₹1,939 Cr | 2.09 | |
Sep2022 | ₹1,899 Cr | 101.75 | |
Jun2022 | ₹941 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -7.94 % |
Y-o-Y | 5.97 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 25.74% | -7.94 | |
Dec2023 | 27.96% | -3.88 | |
Sep2023 | 29.09% | -4.65 | |
Jun2023 | 30.51% | 25.61 | |
Mar2023 | 24.29% | -14.92 | |
Dec2022 | 28.55% | -4.80 | |
Sep2022 | 29.99% | 66.70 | |
Jun2022 | 17.99% | - |
DR REDDYS LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -5.22 % |
Y-o-Y | 37.14 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,306 Cr | -5.22 | |
Dec2023 | ₹1,378 Cr | -6.75 | |
Sep2023 | ₹1,478 Cr | 5.52 | |
Jun2023 | ₹1,401 Cr | 47.06 | |
Mar2023 | ₹953 Cr | -23.06 | |
Dec2022 | ₹1,238 Cr | 12.52 | |
Sep2022 | ₹1,100 Cr | -6.73 | |
Jun2022 | ₹1,180 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -3.57 % |
Y-o-Y | 21.75 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 18.36 % | -3.57 | |
Dec2023 | 19.04 % | -11.07 | |
Sep2023 | 21.41 % | 3.28 | |
Jun2023 | 20.73 % | 37.47 | |
Mar2023 | 15.08 % | -17.28 | |
Dec2022 | 18.23 % | 4.89 | |
Sep2022 | 17.38 % | -22.89 | |
Jun2022 | 22.54 % | - |
DR REDDYS LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -5.15 % |
Y-o-Y | 36.27 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹78.53 | -5.15 | |
Dec2023 | ₹82.79 | -6.83 | |
Sep2023 | ₹88.86 | 5.37 | |
Jun2023 | ₹84.33 | 46.33 | |
Mar2023 | ₹57.63 | -22.81 | |
Dec2022 | ₹74.66 | 11.50 | |
Sep2022 | ₹66.96 | -6.28 | |
Jun2022 | ₹71.45 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD